Padmalal Gurugama

Hills Road
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Management of hereditary angioedema in the UK: a comparison with international guidelines.

Management of hereditary angioedema in the UK: a comparison with international guidelines.

Journal: Clinical and experimental immunology
Published: June 17, 2026

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

Journal: The New England journal of medicine
Published: June 15, 2026

Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial.

Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Haematology
Published: September 08, 2025

A Safe and Effective 7 Week Updosing Protocol for Bee and Wasp Venom Immunotherapy.

A Safe and Effective 7 Week Updosing Protocol for Bee and Wasp Venom Immunotherapy.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 15, 2025

CRISPR-Based Therapy for Hereditary Angioedema.

CRISPR-Based Therapy for Hereditary Angioedema.

Journal: The New England journal of medicine
Published: October 24, 2024

CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.

CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.

Journal: The New England journal of medicine
Published: January 31, 2024

CXCL13 as a Biomarker of Complex Common Variable Immunodeficiency.

CXCL13 as a Biomarker of Complex Common Variable Immunodeficiency.

Journal: Journal of clinical immunology
Published: May 19, 2023

A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom.

A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom.

Journal: The journal of allergy and clinical immunology. In practice
Published: July 31, 2022

Specialist allergy advice allows vaccination in patients with reactions to COVID-19 vaccines.

Specialist allergy advice allows vaccination in patients with reactions to COVID-19 vaccines.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: September 07, 2021

The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.

The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: July 06, 2021

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: March 11, 2021

Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency1.

Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency1.

Journal: Clinical and experimental immunology
Published: October 25, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026